Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
157 Leser
Artikel bewerten:
(0)

Groundbreaking Medical News Presented This Week At Heart Rhythm 2014

SAN FRANCISCO, May 10, 2014 /PRNewswire/ --This week at Heart Rhythm 2014, the Heart Rhythm Society's (HRS) 35th Annual Scientific Sessions, new research was unveiled that will advance the electrophysiology (EP) field and ultimately improve overall patient care.

To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/7224551-heart-rhythm-2014-groundbreaking-medical-news-presented

The Heart Rhythm Society 2014 Annual Meeting - Opening Session in San Francisco

The meeting included internationally recognized speakers and a wide variety of sessions that offered attendees first-hand knowledge and a chance to engage in the emerging technologies of the future.

Three feature studies presented at Heart Rhythm 2014 this week include:

  • Insurance & Gender Disparities in Care: For the first time in nearly a decade, new analysis of ICD implants in the United States shows a majority of implants are performed on people with insurance and more commonly in the male population...read more.
  • Heart Screenings & Young Athletes: New study found that adding an electrocardiogram (ECG) to existing pre-participation screening of high school athletes increases the likelihood of identifying disorders associated with sudden cardiac death...read more.
  • Weight-loss Surgery & Heart Health: New research found bariatric surgery, or weight loss surgery, to be an effective way to control weight in morbidly obese patients who are at risk for developing life-threatening arrhythmia, called atrial fibrillation...read more.

Heart Rhythm 2014 will conclude on Saturday, May 10th in San Francisco. For more information about additional research presented at Scientific Sessions this week, please visit www.HRSonline.org/sessions.

Heart Rhythm 2015 will be held in Boston next May.

About the Heart Rhythm Society

The Heart Rhythm Society is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. Incorporated in 1979 and based in Washington, DC, it has a membership of more than 5,800 heart rhythm professionals in more than 72 countries around the world. For more information, visit www.HRSonline.org.

CONTACT: Kennesha Baldwin: (202) 590-6757,Allison Kassel: (904) 728-2145

Dr. Robert Giugliano speaks during the Late-Breaking Clinical Trials Session II Press Briefing at the Heart Rhythm Society 2014 Annual Meeting in San Francisco.

More than 15,000 physicians, researchers, health care professionals and patient advocates attended the Heart Rhythm Society Annual Meeting at the Moscone Center in San Francisco.

The Heart Rhythm Society 2014 Annual Meeting in San Francisco

To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/7224551-heart-rhythm-2014-groundbreaking-medical-news-presented

SOURCE Heart Rhythm Society

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.